Cargando…

Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis

Detalles Bibliográficos
Autores principales: Mantero, Vittorio, Baroncini, Damiano, Balgera, Roberto, Guaschino, Clara, Basilico, Paola, Annovazzi, Pietro, Zaffaroni, Mauro, Salmaggi, Andrea, Cordano, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457441/
https://www.ncbi.nlm.nih.gov/pubmed/32865629
http://dx.doi.org/10.1007/s00415-020-10196-9
_version_ 1783575994233257984
author Mantero, Vittorio
Baroncini, Damiano
Balgera, Roberto
Guaschino, Clara
Basilico, Paola
Annovazzi, Pietro
Zaffaroni, Mauro
Salmaggi, Andrea
Cordano, Christian
author_facet Mantero, Vittorio
Baroncini, Damiano
Balgera, Roberto
Guaschino, Clara
Basilico, Paola
Annovazzi, Pietro
Zaffaroni, Mauro
Salmaggi, Andrea
Cordano, Christian
author_sort Mantero, Vittorio
collection PubMed
description
format Online
Article
Text
id pubmed-7457441
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74574412020-09-01 Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis Mantero, Vittorio Baroncini, Damiano Balgera, Roberto Guaschino, Clara Basilico, Paola Annovazzi, Pietro Zaffaroni, Mauro Salmaggi, Andrea Cordano, Christian J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-08-31 2021 /pmc/articles/PMC7457441/ /pubmed/32865629 http://dx.doi.org/10.1007/s00415-020-10196-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editors
Mantero, Vittorio
Baroncini, Damiano
Balgera, Roberto
Guaschino, Clara
Basilico, Paola
Annovazzi, Pietro
Zaffaroni, Mauro
Salmaggi, Andrea
Cordano, Christian
Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title_full Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title_fullStr Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title_full_unstemmed Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title_short Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
title_sort mild covid‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457441/
https://www.ncbi.nlm.nih.gov/pubmed/32865629
http://dx.doi.org/10.1007/s00415-020-10196-9
work_keys_str_mv AT manterovittorio mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT baroncinidamiano mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT balgeraroberto mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT guaschinoclara mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT basilicopaola mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT annovazzipietro mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT zaffaronimauro mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT salmaggiandrea mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis
AT cordanochristian mildcovid19infectioninagroupofteriflunomidetreatedpatientswithmultiplesclerosis